CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
Acceleration to Clinic Grant supports investigator teams validating ovarian cancer biomarkers, pairing research funding with expert advice to advance early detection or interception toward clinical use.
Acceleration Initiative Award supports researchers pursuing translational and preclinical pediatric cancer treatment research to overcome development barriers and reach clinical trials within three years.
Lustgarten Foundation Innovation and Collaboration Program supports researchers tackling outstanding pancreatic cancer questions through innovative studies aimed at making the disease curable.
Academic Clinical Trials Program (ACT) supports academic investigators conducting blood cancer trials to test new treatments, expand existing therapy uses, and improve care for unmet medical needs.